Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5087821
Max Phase: Preclinical
Molecular Formula: C16H27NO14
Molecular Weight: 457.39
Molecule Type: Unknown
Associated Items:
ID: ALA5087821
Max Phase: Preclinical
Molecular Formula: C16H27NO14
Molecular Weight: 457.39
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C16H27NO14/c17-1-2-27-3-4-28-15-9(22)7(20)10(12(31-15)14(25)26)29-16-8(21)5(18)6(19)11(30-16)13(23)24/h5-12,15-16,18-22H,1-4,17H2,(H,23,24)(H,25,26)/t5-,6-,7+,8+,9+,10-,11+,12+,15+,16+/m0/s1
Standard InChI Key: JAZUKQXVKRCSTI-AFZWUWRASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.39 | Molecular Weight (Monoisotopic): 457.1432 | AlogP: -5.21 | #Rotatable Bonds: 10 |
Polar Surface Area: 247.92 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.84 | CX Basic pKa: 9.44 | CX LogP: -6.80 | CX LogD: -9.98 |
Aromatic Rings: 0 | Heavy Atoms: 31 | QED Weighted: 0.14 | Np Likeness Score: 1.28 |
1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R.. (2021) Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development., 64 (6.0): [PMID:33683903] [10.1021/acs.jmedchem.0c01800] |
Source(1):